Design and Evaluation of PEGylated Liposomal Formulation of a Novel Multikinase Inhibitor for Enhanced Chemosensitivity and Inhibition of Metastatic Pancreatic Ductal Adenocarcinoma.

Madamsetty, Vijay Sagar

Design and Evaluation of PEGylated Liposomal Formulation of a Novel Multikinase Inhibitor for Enhanced Chemosensitivity and Inhibition of Metastatic Pancreatic Ductal Adenocarcinoma. [electronic resource] - Bioconjugate chemistry 10 2019 - 2703-2713 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1520-4812

10.1021/acs.bioconjchem.9b00632 doi


Adenocarcinoma--pathology
Animals
Apoptosis--drug effects
Cell Line, Tumor
Cell Proliferation--drug effects
Deoxycytidine--analogs & derivatives
Drug Compounding
Drug Design
ErbB Receptors--metabolism
Female
Humans
Liposomes--chemistry
Mice
Neoplasm Metastasis
Pancreatic Neoplasms--pathology
Polyethylene Glycols--chemistry
Protein Kinase Inhibitors--chemistry
Proteolysis--drug effects
Xenograft Model Antitumor Assays
Gemcitabine